Bioventix (LON:BVXP) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?

Bioventix PLC (LON:BVXPGet Free Report) shares passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 1,698.59 and traded as high as GBX 1,750. Bioventix shares last traded at GBX 1,711, with a volume of 3,328 shares trading hands.

Bioventix Stock Performance

The firm has a market capitalization of £89.40 million, a P/E ratio of 12.18 and a beta of 0.55. The firm’s 50-day moving average is GBX 1,698.59 and its 200 day moving average is GBX 1,697.74.

Bioventix (LON:BVXPGet Free Report) last issued its earnings results on Monday, March 30th. The biotechnology company reported GBX 69.38 earnings per share for the quarter. Bioventix had a net margin of 59.30% and a return on equity of 65.83%. The firm had revenue of GBX 615.88 billion for the quarter. As a group, research analysts expect that Bioventix PLC will post 166.3066955 EPS for the current fiscal year.

Insider Buying and Selling at Bioventix

In related news, insider Bruce Hiscock bought 66 shares of the business’s stock in a transaction on Monday, April 27th. The shares were purchased at an average price of GBX 1,679 per share, for a total transaction of £1,108.14. Also, insider Ian James Nicholson bought 1,000 shares of the business’s stock in a transaction on Friday, April 10th. The stock was bought at an average price of GBX 1,848 per share, for a total transaction of £18,480. Insiders have purchased 2,131 shares of company stock worth $3,927,999 over the last quarter. Corporate insiders own 6.22% of the company’s stock.

Bioventix Company Profile

(Get Free Report)

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Read More

Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.